• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发现新型和强效的 - 甲基 - D- 天冬氨酸受体正变构调节剂,在啮齿动物模型中具有抗抑郁样活性。

Discovery of Novel and Potent -Methyl-d-aspartate Receptor Positive Allosteric Modulators with Antidepressant-like Activity in Rodent Models.

机构信息

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.

Jiangsu Nhwa Pharmaceutical Co., Ltd. 69 Democratic South Road, Xuzhou, Jiangsu 221116, China.

出版信息

J Med Chem. 2021 May 13;64(9):5551-5576. doi: 10.1021/acs.jmedchem.0c02018. Epub 2021 May 3.

DOI:10.1021/acs.jmedchem.0c02018
PMID:33934604
Abstract

-Methyl-d-aspartate receptors (NMDARs) are glutamate-gated Na and Ca-permeable ion channels involved in excitatory synaptic transmission and synaptic plasticity. NMDAR hypofunction has long been implicated in the pathophysiology including major depressive disorders (MDDs). Herein, we report a series of furan-2-carboxamide analogues as novel NMDAR-positive allosteric modulators (PAMs). Through structure-based virtual screen and electrophysiological tests, FS2921 was identified as a novel NMDAR PAM with potential antidepressant effects. Further structure-activity relationship studies led to the discovery of novel analogues with increased potentiation. Compound caused a significant increase in NMDAR excitability and impressive activity in the forced swimming test. Moreover, compound showed no significant inhibition of hERG or cell viability and possessed a favorable PK/PD profile. Our study presented a series of novel NMDAR PAMs and provided potential opportunities for discovering of new antidepressants.

摘要
  • 甲基-D-天冬氨酸受体(NMDARs)是谷氨酸门控的 Na 和 Ca 通透性离子通道,参与兴奋性突触传递和突触可塑性。NMDAR 功能低下长期以来与包括重度抑郁症(MDDs)在内的病理生理学有关。在此,我们报告了一系列呋喃-2-甲酰胺类似物作为新型 NMDAR 正变构调节剂(PAMs)。通过基于结构的虚拟筛选和电生理测试,鉴定出 FS2921 是一种具有潜在抗抑郁作用的新型 NMDAR PAM。进一步的构效关系研究发现了具有增强作用的新型类似物。化合物 导致 NMDAR 兴奋性显著增加 ,并在强迫游泳试验中表现出显著的活性。此外,化合物 对 hERG 或细胞活力没有明显抑制作用,且具有良好的 PK/PD 特征。我们的研究提出了一系列新型的 NMDAR PAMs,并为发现新型抗抑郁药提供了潜在的机会。

相似文献

1
Discovery of Novel and Potent -Methyl-d-aspartate Receptor Positive Allosteric Modulators with Antidepressant-like Activity in Rodent Models.发现新型和强效的 - 甲基 - D- 天冬氨酸受体正变构调节剂,在啮齿动物模型中具有抗抑郁样活性。
J Med Chem. 2021 May 13;64(9):5551-5576. doi: 10.1021/acs.jmedchem.0c02018. Epub 2021 May 3.
2
Zelquistinel Is an Orally Bioavailable Novel NMDA Receptor Allosteric Modulator That Exhibits Rapid and Sustained Antidepressant-Like Effects.泽利奎斯特内尔是一种口服生物可利用的新型 NMDA 受体变构调节剂,具有快速和持续的抗抑郁样作用。
Int J Neuropsychopharmacol. 2022 Dec 12;25(12):979-991. doi: 10.1093/ijnp/pyac043.
3
Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis.正变构调节作为抗 NMDA 受体脑炎的一种潜在治疗策略。
J Neurosci. 2018 Mar 28;38(13):3218-3229. doi: 10.1523/JNEUROSCI.3377-17.2018. Epub 2018 Feb 23.
4
Discovery of Pyrazolo[1,5-a]pyrazin-4-ones as Potent and Brain Penetrant GluN2A-Selective Positive Allosteric Modulators Reducing AMPA Receptor Binding Activity.发现吡唑并[1,5-a]吡嗪-4-酮类化合物作为强效和脑穿透性的 GluN2A 选择性正变构调节剂,降低 AMPA 受体结合活性。
Bioorg Med Chem. 2022 Feb 15;56:116576. doi: 10.1016/j.bmc.2021.116576. Epub 2021 Dec 16.
5
An Integrated Approach for Screening and Identification of Positive Allosteric Modulators of N-Methyl-D-Aspartate Receptors.一种用于筛选和鉴定 N-甲基-D-天冬氨酸受体正变构调节剂的综合方法。
J Biomol Screen. 2016 Jun;21(5):468-79. doi: 10.1177/1087057116628437. Epub 2016 Feb 2.
6
Positive modulation of NMDA receptors by AGN-241751 exerts rapid antidepressant-like effects via excitatory neurons.AGN-241751对NMDA受体的正向调节通过兴奋性神经元发挥快速的抗抑郁样作用。
Neuropsychopharmacology. 2021 Mar;46(4):799-808. doi: 10.1038/s41386-020-00882-7. Epub 2020 Oct 15.
7
Does increasing the ratio of AMPA-to-NMDA receptor mediated neurotransmission engender antidepressant action? Studies in the mouse forced swim and tail suspension tests.增加 AMPA 型谷氨酸受体与 NMDA 型谷氨酸受体介导的神经递质传递是否会产生抗抑郁作用?在小鼠强迫游泳和悬尾试验中的研究。
Neurosci Lett. 2013 Jun 24;546:6-10. doi: 10.1016/j.neulet.2013.04.045. Epub 2013 May 2.
8
Allosteric modulators of NMDA receptors: multiple sites and mechanisms.N-甲基-D-天冬氨酸受体的变构调节剂:多个位点与机制
Curr Opin Pharmacol. 2015 Feb;20:14-23. doi: 10.1016/j.coph.2014.10.009. Epub 2014 Nov 12.
9
NMDAR PAMs: Multiple Chemotypes for Multiple Binding Sites.NMDAR 变构调节剂:多种化学型作用于多个结合位点。
Curr Top Med Chem. 2019;19(24):2239-2253. doi: 10.2174/1568026619666191011095341.
10
The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors.主要脑胆固醇代谢产物 24(S)-羟基胆固醇是 N-甲基-D-天冬氨酸受体的有效别构调节剂。
J Neurosci. 2013 Oct 30;33(44):17290-300. doi: 10.1523/JNEUROSCI.2619-13.2013.

引用本文的文献

1
Research Progress on NMDA Receptor Enhancement Drugs for the Treatment of Depressive Disorder.NMDA 受体增敏剂治疗抑郁症的研究进展。
CNS Drugs. 2024 Dec;38(12):985-1002. doi: 10.1007/s40263-024-01123-x. Epub 2024 Oct 8.
2
Discovery of GluN2A subtype-selective -methyl-d-aspartate (NMDA) receptor ligands.谷氨酸N2A亚型选择性 - 甲基 - D - 天冬氨酸(NMDA)受体配体的发现。
Acta Pharm Sin B. 2024 May;14(5):1987-2005. doi: 10.1016/j.apsb.2024.01.004. Epub 2024 Jan 10.
3
Carbazole and tetrahydro-carboline derivatives as dopamine D receptor antagonists with the multiple antipsychotic-like properties.
咔唑和四氢咔啉衍生物作为具有多种抗精神病样特性的多巴胺 D 受体拮抗剂。
Acta Pharm Sin B. 2023 Nov;13(11):4553-4577. doi: 10.1016/j.apsb.2023.07.024. Epub 2023 Jul 27.
4
GluN2B-containing NMDARs in the mammalian brain: pharmacology, physiology, and pathology.哺乳动物大脑中含GluN2B的N-甲基-D-天冬氨酸受体:药理学、生理学及病理学
Front Mol Neurosci. 2023 May 31;16:1190324. doi: 10.3389/fnmol.2023.1190324. eCollection 2023.
5
In silico and in vivo neuropharmacological evaluation of two γ-amino acid isomers derived from 2,3-disubstituted benzofurans, as ligands of GluN1-GluN2A NMDA receptor.计算机模拟和体内神经药理学评价两种来源于 2,3-二取代苯并呋喃的γ-氨基酸异构体作为 GluN1-GluN2A NMDA 受体配体的活性。
Amino Acids. 2022 Feb;54(2):215-228. doi: 10.1007/s00726-021-03108-2. Epub 2021 Dec 2.